Research & Development
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
30 January 2026 - Clinical-stage biopharmaceutical company MicuRx Pharmaceuticals Inc announced on Thursday that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND...
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
29 January 2026 - Biotechnology company Tenpoint Therapeutics Ltd announced on Thursday that the US Food and Drug Administration (FDA) has approved YUVEZZI (carbachol and brimonidine tartrate ophthalm...
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
29 January 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) announced on Thursday that the US Food and Drug Administration (FDA) has accepted its Biologics License Appli...
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
29 January 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Wednesday that it has formed a collaboration with ...
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
28 January 2026 - Biotechnology company Biogen Inc (Nasdaq:BIIB) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for litifilimab (BII...
Glaukos receives FDA approval for repeat administration of iDose TR
28 January 2026 - Ophthalmic pharmaceuticals and medical technology company Glaukos Corporation (NYSE:GKOS) announced on Wednesday that the US Food and Drug Administration (FDA) has approved a new dru...